Revance Therapeutics, Inc. - COM (RVNC)

Q3 2019 13F Holders as of 9/30/2019

Type / Class
Equity / COM
Number of holders
107
Total Shares
42.6M
Shares change
-927K
Total reported value, excl. options
$554M
Value change
-$12M
Put/Call ratio
1.66
Number of buys
60
Number of sells
-38
Price
$13.00
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.